Figure 2From: Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related dataProportion of studies by staff member(s) who question participants about health and drug use (N = 52). “Other” most frequently referred to community health workers, field workers and various trained members of the research team.Back to article page